Recent Headlines
Within Pharmaceuticals
Microvascular Therapeutics: Positive Clinical Trial Results with Lead Candidate, CardiSon (MVT-100)
Microvascular Therapeutics, Inc. (MVT), a biotechnology company, announced that it has completed data analysis of its Phase II trial of its new ultrasound contrast agent, MVT-100, CardiSon, in echocardiography. In this study, 16 subjects received either the predicate agent Perflutren, or CardiSon,... - May 15, 2025 - Microvascular Therapeutics, Inc.
Bench International Launches Bench On Demand to Deliver Executive Leadership at Fractional and Interim Capacity
Bench International, the longest-serving woman-founded executive search firm in the life sciences industry, today announced the launch of Bench On Demand, a new service offering flexible access to A-level executive talent on a fractional or interim basis. This initiative expands Bench’s... - May 13, 2025 - Bench International
Truvy® and Sweet Minerals Partner to Expand Global Health & Beauty Opportunities via Bytru.com
Truvy® has integrated the product and multi-level marketing (MLM) operations of Sweet Minerals into its business at Bytru, making Sweet Minerals’ celebrated beauty products available to a broader global audience. - May 12, 2025 - Truvy
ReLiftMD Reports Over 2,000 Successful Patient Treatments -- Re•Lift Me™ One-Hour Facial Rejuvenation Procedures Deliver Decade-Younger Looks Under Local Anesthesia
ReLiftMD LLC is changing the aesthetic landscape with its novel Re•Lift Me™ minimally invasive, long-lasting facial rejuvenation procedures. These procedures enable individuals to achieve a naturally youthful appearance, looking up to ten years younger, through a simple, one-hour procedure performed under local anesthesia. - May 07, 2025 - ReLiftMD, LLC
Industry-First Platform Combines AI-Powered Simulation and Lab Testing for Faster Biodegradation Assessment
Aropha's Biodegradation Studio is transforming how product developers approach biodegradability testing. The new platform combines rapid, AI-powered simulation with accredited laboratory services. Users can manage and accelerate every stage of biodegradability testing — from virtual screening to lab validation —through one, centralized hub. The studio helps R&D teams cut costs, screen more chemicals, speed up development and bring biodegradable materials to market faster. - May 06, 2025 - Aropha
Hemanext Expands Board of Directors with Two New Members
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, announces the appointment of two distinguished professionals to its Board of Directors. Joe Grogan and Phil Pead join the visionary leaders that are steering Hemanext’s path to improving the standard... - May 05, 2025 - Hemanext
MindScape Retreat Releases Landmark Case Study Showing 70% Average Symptom Improvement in Parkinson’s Patients Following Ibogaine Treatment in Mexico
MindScape Retreat in Cozumel, Mexico has released a groundbreaking case study showing a 70% average improvement in Parkinson’s symptoms following a 14-day ibogaine therapy program. Among 30 patients, 52% symptom relief was seen by Day 4, with further gains by Day 14. A quarter of participants who continued microdosing post-retreat maintained or improved results. The therapy, using Ibogaine HCl and TA, showed strong safety and potential neuroregenerative benefits via GDNF activation. - May 02, 2025 - MindScape Retreat
AffinIT Secures $600,000 Funding Round to Accelerate Growth in Managed IT Services
AffinIT, a managed IT services provider, secured $600K funding to expand its AI-powered platform for small and mid-market companies. Founded in 2024, AffinIT offers end-user support, network management, cybersecurity and cloud solutions. The funding will support growth and product development after a year of 100% revenue growth. - May 02, 2025 - AffinIT, LLC
Vetirus Pharmaceuticals Acquires Enso Discoveries to Expand Regenerative Medicine Portfolio
Vetirus Pharmaceuticals, a multinational company headquartered in Naples, Florida, and London, UK, announced its acquisition of Enso Discoveries, LLC, a Manhattan, Kansas-based biotech company specializing in regenerative medicine. The acquisition was revealed at the 10th annual Animal Health, Nutrition, and Technology Innovation Europe. - April 30, 2025 - Vetirus Animal Health
Mirror Biologics Announces Publication of Clinical Results Showing Potential for Allo-Priming to Provide Broad Protection to Elderly from Respiratory Viral Infection
A new approach for pandemic preparedness and protection of the elderly from any type of respiratory viral infection. Five injections over two weeks provides possible universal viral protection without need for booster shots. - April 28, 2025 - Mirror Biologics, Inc.
International Vitamin Corporation (IVC) Appoints Nora Dowell as Senior Vice President of Quality, Regulatory, and R&D
IVC is pleased to announce the appointment of Nora Dowell as Senior Vice President of Quality, Regulatory, and R&D, marking a significant step forward in the company’s ongoing commitment to delivering high-quality, compliant, and innovative health and wellness products. Nora brings more than 30 years of experience in regulatory compliance and quality management systems, with deep expertise in cGMP, QMS, FSMA/FSVP, training, auditing, labeling, and supplier qualifications. - April 26, 2025 - International Vitamin Corporation
MindScape Retreat in Cozumel, Mexico, Offers Innovative Ibogaine Therapy to Address Long-Term SSRI Effects and Serotonin Syndrome Risks
MindScape Retreat in Cozumel, Mexico, offers medically supervised ibogaine treatment to help individuals safely discontinue SSRIs and address associated long-term effects, including the risk of serotonin syndrome. By promoting neuroplasticity and restoring neurotransmitter balance, ibogaine therapy at an Ibogaine Retreat called MindScape Retreat provides a holistic approach to mental health recovery in a serene and supportive environment. - April 25, 2025 - MindScape Retreat
Precision Antibody’s Founder and CEO to Speak at the 2025 Drug Discovery Strategic Summit in Boston
Dr. Jun Hayashi and Dr. Ginette Serrero of Precision Antibody will speak at the 2025 Drug Discovery Strategic Summit in Boston, highlighting advances in monoclonal antibody development and its role in accelerating drug discovery. - April 25, 2025 - Precision Antibody
Caris Life Sciences Collaborates with Meaningful Insights Biotech Analytics (MiBA) to Advance Oncology Education and Quality of Care
Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced a strategic collaboration with MiBA, an innovative healthcare technology company to provide physician education and insights to accelerate research, identify and... - April 24, 2025 - MiBA
Parvus Announces Achievement of First Milestone from its Collaboration Agreement with AbbVie to Develop IBD Therapies Based on the Parvus Nanomedicine Platform Technology
IND-enabling nonclinical and manufacturing activities executed by Parvus met prospective criteria resulting in the first milestone payment from AbbVie. - April 21, 2025 - Parvus Therapeutics U.S., Inc.
New GDP Training with Certificate
Pharma Lessons has launched another new online training. This time the topic is Good Distribution Practice. The training explores the regulatory guidelines that govern the wholesale distribution of medicinal products. Trainees that decide to enroll into that course will get familiar with the main... - April 16, 2025 - Pharma Lessons
Ember Group Consulting & Ember Group Search Bolsters Talent Acquisition Capabilities with Appointment of Taylor Morrison as VP of Talent & MD of Ember Group Search
Ember Group appoints Taylor Morrison as VP of Talent & Managing Director of Ember Group Search. With 20+ years of global talent acquisition experience, Taylor will lead the firm's talent acquisition function, focusing on identifying and retaining top talent to drive business growth and spark careers. - April 15, 2025 - Ember Group Consulting LLC
GENINVO Announces Its Latest Innovation – Confidential Information Scanner (CIS) Tool
GENINVO, a leading provider of life science technology solutions, is proud to announce the launch of its latest innovation – the Confidential Information Scanner (CIS) Tool. This tool is designed to help organizations identify publicly available company confidential information (CCI) across... - April 12, 2025 - GenInvo, Inc.
Devonics Automation (Booth #4413) to Participate in Automate 2025, May 12–15, in Detroit, Michigan, USA
Devonics Automation will showcase collaborative robot (cobot) solutions designed to meet growing automation demands at the most influential automation event in the Americas. - April 07, 2025 - Devonics Automation
Minus K Congratulates to the following winners of their 2024/2025 Educational Giveaway
Celebrating its’ tenth year of their U.S. Educational Giveaway, Minus K Technology has to-date granted over $100,000 of its superior performing patented Negative-Stiffness low-frequency passive mechanical vibration isolators to colleges and universities in the USA. - April 03, 2025 - Minus K Technology Inc.
Wallflower Cannabis House Announces Second Location in Inspirada, Henderson
Wallflower Cannabis House, a renowned dispensary for Las Vegas locals, is thrilled to announce the opening of its second location on April 4 at 8am in the Inspirada area of Henderson, at 3485 Volunteer Blvd. Building on the success of its original location on Blue Diamond Road since 2020,... - April 02, 2025 - Wallflower Cannabis House
Apeximmune Therapeutics Announces Successful Close of Series A Fundraising Round to Advance Next-Generation Immunotherapies
Apeximmune Therapeutics, a biotechnology company pioneering next-generation immunotherapies, today announced the successful close of its Series A financing round, raising $21.3 million, exceeding its original goal of $20 million. The funding was led by PharmaEssentia Corporation, with participation... - April 01, 2025 - Apeximmune Therapeutics
Huntington Study Group Announces Executive Director of Clinical Operations
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to introduce Carolyn Schultz-Walter as the Executive Director of Clinical Operations. With over 25 years of global clinical operations experience spanning both sponsor and clinical research... - March 31, 2025 - Huntington Study Group
BlueCallom Launches COMPLY-AI, Challenging the $36 Billion Industry with a New AI Solution
BlueCallom today announced the launch of COMPLY-AI, an autonomous compliance management solution designed to support enterprise teams in meeting evolving regulatory requirements. COMPLY-AI offers an integrated platform that delivers self-service compliance assessments, saving over 2,000 expert hours annually. It also reduces operational delays and improves the time-to-market. - March 29, 2025 - BlueCallom AG
Dr. Mike Chan: Leading the Future of Organ-Specific Stem Cell Therapies with Revolutionary Treatments in Regenerative Medicine
Dr. Mike Chan is a global leader in regenerative medicine, transforming lives with stem cells, exosomes, and peptides. His innovative treatments regenerate tissues, restore healing, and enhance vitality. Patients experience renewed hope, improved energy, and recovery from chronic conditions. His groundbreaking work is reshaping the future of healthcare. - March 28, 2025 - Dr. Mike Chan
Carl Wittwer, MD, PhD, Joins PathogenDx’s Board of Advisors
Carl Wittwer, MD PhD, Professor Emeritus of Pathology at the University of Utah, a Co-Founder of Idaho Technologies/Biofire and previously spent 35+ years as a Medical Director at ARUP Laboratories is joining PathogenDx as Technology & Scientific Board Advisor to help advance its D3 Array technology in terms of Speed, Cost and Performance. - March 25, 2025 - PathogenDx, Inc.
Thar Process and Clean Heat Technologies Integrate CO2 Heat Pump Technology to Make Supercritical CO2 Technology a Low Cost Solution
Thar Process and Clean Heat Technologies have successfully engineered, integrated and installed electric heat pumps using CO2 - R744 - as the upcycled, natural refrigerant. The technology partnership means that Thar Process' clients can benefit from lower operating costs. Thar is known for it's innovative use of CO2 for extracting flavors, fragrances, medicinal and therapeutic compounds both in it's GMP certified facility in Pittsburgh and at client sites globally. - March 24, 2025 - Thar Process
SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug for the Treatment of Cancer at the American Association for Cancer Research (AACR) Annual Meeting 2025
SignaBlok will present positive preclinical data on targeting innate inflammation for the treatment of hard-to-treat cancers. In combination with standard-of-care chemotherapy, SignaBlok's new mechanism-based inhibitor of TREM-1, an inflammation amplifier, prevents cancer recurrence, improves complete response rate and survival in experimental pancreatic cancer. In combination with anti-PD-L1 treatment, it overcomes pancreatic cancer resistance to immunotherapy. - March 21, 2025 - SignaBlok, Inc.
SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug at the Respiratory Innovation Summit and American Thoracic Society International Conference 2025
SignaBlok will present positive preclinical data on targeting innate inflammation for the treatment of sepsis and pulmonary diseases. In experimental sepsis, SignaBlok's new mechanism-based inhibitor of TREM-1, an inflammation amplifier, protects from death with the level of protection not declining at delayed treatment times. In pulmonary inflammation and fibrosis in rats and mice, it reduces neutrophil infiltration in the lungs and reverses fibrosis. - March 21, 2025 - SignaBlok, Inc.
Addressing the Growing Crisis in Pain Management Medication Access
PMC Pharmacy Advocates for Transparent, Collaborative Solutions to Reduce Risk and Ensure Patient Care - A Path Forward for Pain Management Medication Access - March 19, 2025 - PMC Pharmacy
ALS Therapy Development Institute Joins DataCite to Expand Access and Impact of ARC Dataset
The ALS Therapy Development Institute (ALS TDI) is pleased to announce its acceptance as a member of DataCite, a leading global organization dedicated to ensuring research is openly available and accessible across scientific disciplines. This partnership will significantly enhance the... - March 18, 2025 - ALS Therapy Development Institute
Samantha's Outings Celebrates a Year of Empowerment and Community Engagement for Individuals with Autism
What Samantha's Outings has done in one year and where they will go in the future. - March 17, 2025 - Samantha's Outings
ConductScience Accepted Into NVIDIA Connect Program, Advancing AI-Driven Behavioral Neuroscience Research Solutions
ConductScience joins the NVIDIA Connect program, accelerating AI advancements in behavioral research. This collaboration enhances ConductVision, ConductInsecta, ConductNest, and GaitMaster, optimizing research on locomotion, cognition, and social behavior across species. With NVIDIA’s support, ConductScience gains access to GPU-accelerated computing, engineering resources, and training, driving innovation in neuroscience, genetics, and medicine. - March 16, 2025 - ConductScience
Trailhead Biosystems® Develops iPSC-Derived Vascular Leptomeningeal Cells
Trailhead Biosystems, Inc. announces the launch of TrailBio® Vascular Leptomeningeal Cells. - March 12, 2025 - Trailhead Biosystems, Inc.
BlueCallom Launches AgenticBlue: Transforming AI from a Shadowy Sidekick to a Mission-Critical Enterprise Investment
BlueCallom, a pioneer in Agentic AI Business Solutions, announced the launch of AgenticBlue, its a breakthrough Enterprise AI Management Platform. Designed to manage all unsupervised AI properties such as Prompts, Agents, and Multi-Agent solutions into strategically aligned, mission-critical investments. Those AI assets already represent a significant value. - March 12, 2025 - BlueCallom AG
eg technology Bolsters Global Presence with Appointment of Paul Anglim
eg technology Ltd. make key appointment as Paul Anglim joins the specialist product design, engineering and development consultancy as they continue their international expansion. - March 11, 2025 - eg technology Ltd
West Bengal Chemical Industries Limited Introduces Liposomal Skincare Technology
Liposomal technology, an advance technology, involves encapsulating active ingredients within lipid bilayers. - March 11, 2025 - West Bengal Chemical Industries Limited
New Bonus Modules for the Certificate GMP Training
Pharma Lessons has added two new bonus modules to the popular Good Manufacturing Practice Training. The new modules are already available to all currently enrolled users. The first module covers the major differences between the FDA and EMA GMP guidelines. And the second module is based on the GMP... - March 09, 2025 - Pharma Lessons
Cenmed and ENG Scientific Partner to Deliver High-Quality Kitting and Custom Chemical Filling Solutions
Cenmed Enterprises and ENG Scientific have expanded their partnership to enhance kitting and custom chemical filling services for laboratories, biotech companies, and healthcare institutions. By combining Cenmed’s supply chain expertise with ENG’s chemical formulation capabilities, the collaboration streamlines reagent kit production, specimen collection solutions, and bulk chemical filling. This partnership strengthens Cenmed’s ability to deliver efficient, compliant, and scalable solutions. - March 07, 2025 - Cenmed
HistAI Unveils Groundbreaking SPIDER Initiative at HIMSS Conference
At the HIMSS Conference, HistAI announced the SPIDER Initiative, an open-source project set to become the largest supervised medical imaging dataset. The initiative will compile more than 50 millions of fully annotated images from 20 organs and 400 morphologies, advancing AI-driven diagnostics, precision medicine, and drug development. The first release includes more than 4 millions of images from 6K Whole Slide Images (WSIs) across Skin, Colorectal, and Thorax. Available starting today. - March 06, 2025 - HistAI
matrihealth GmbH Qualifies Soluble Elastin Hydrolysate matripure® for Use in Cosmetics
matrihealth GmbH has qualified matripure® elastin for use in cosmetics, providing manufacturers with a high-quality raw material made in Germany. - March 06, 2025 - matrihealth GmbH
Regenexx® Corporate Program's Dr. Mark Testa Wins the YOU Powered Symposium 2025 Most Influential Clinician in Insurance Award
The YOU Powered Symposium is the leading annual event for "bold benefits trailblazers." It brings together hundreds of benefit professionals, solution providers, clinicians, and employers to combine diverse expertise in an effort to reform the US healthcare system on behalf of every patient. - March 04, 2025 - Regenexx Corporate Program
AI MINDSystems Foundation and GenoBank.io Announce Strategic Partnership at ETHDenver to Advance Decentralized Biobanking and Healthcare Innovation
AI MINDSystems and GenoBank.io partner at ETHDenver to advance decentralized biobanking. Integrating GenoBank.io’s BioNFT™ into the AI MINDSystems Trusted Data Ecosystem™ empowers individuals with control over their biosamples via ‘lockable’ NFTs. This collaboration aims to create secure, privacy-preserving solutions for digital biology, precision health, and research, using blockchain and Web3 technologies. They also plan to launch WISDOM Networks™ for data-driven healthcare transformation. - February 28, 2025 - AI MINDSystems Foundation
Trump-Era Administration Drug Development & Outsourcing Impact Report
How Tariffs and RFK Jr.’s HHS Appointment May Shift Drug Development & Outsourcing - February 27, 2025 - Life Science Strategy Group, LLC
Purity Health, LLC Announces Lora Harnack as New Chief Executive Officer
Purity Health, LLC has appointed Lora Harnack as its new Chief Executive Officer, with former CEO Rob Bramblett transitioning to President. Harnack, a Tennessee native with 30 years of healthcare leadership experience, has held executive roles in hospital administration, healthcare IT, and nonprofit organizations, most recently leading the Cumberland Pediatric Foundation. - February 21, 2025 - Purity Health, LLC
PathogenDx Launches Its Rebranded D3 Array™ Combined, Bacterial and Fungal Assays—Delivering Value in Turn-Around Time, Cost and Throughput to Testing Labs
PathogenDx, a leader in next-generation microarray technology for better health and safety, announced the launch of its new rebranded D3 Array™ Combined, Bacterial and Fungal assays to replace Detectx–Combined,Detectx-Bacterial and Detectx-Fungal tests. - February 20, 2025 - PathogenDx, Inc.
Two Peoria Residents Win $20,000 in National Transformation Contest
Wayne Galpin and Kaitlyn Willis of FXB Peoria have won the 2024 Farrell’s National Challenge, each earning $10,000 for their remarkable yearlong fitness transformations. Farrell’s eXtreme Bodyshaping (FXB) combines kickboxing, strength training, nutrition coaching, and accountability to help members achieve lasting health results. Their dedication not only transformed their lives but also inspired their community. - February 19, 2025 - Farrell's Extreme Body Shaping
New Book "Messy Mind, Brilliant Life" Empowers ADHD Individuals to Thrive; Dr. Heather Wisdom’s Guide to Unlocking the Power of the ADHD Brain
Author and podcast host Dr. Heather Wisdom announces the release of Messy Mind, Brilliant Life: A Practical Guide to Thriving with ADD/ADHD. This book reframes ADHD as a unique way of thinking rather than a deficit and offers strategies for harnessing its strengths. - February 19, 2025 - Dr. Heather Wisdom
Health Response Alliance Launched to Unify Disaster Response Efforts Across Sectors
Health Response Alliance (HRA) unites public, private, and nonprofit partners to strengthen disaster response. Led by CEO Tom Cotter, HRA streamlines resource-sharing and coordination, emphasizing cross-sector collaboration and early-stage crisis intervention. With evolving federal policies, HRA fills gaps by fostering cooperation among health agencies and other key stakeholders, ensuring communities receive timely, equitable, and effective support during emergencies. - February 19, 2025 - Health Response Alliance
Young Adults with Special Needs Face Critical Gap in Support Services; Samantha's Outings Provides Vital Community Resource
There's a void in aid once children with special needs become adults, Samantha's Outings aims to fill that void. - February 18, 2025 - Samantha's Outings